Article Text
Abstract
Background Although preventable, adverse childhood experiences (ACEs) can result in lifelong health harms. Current surveillance data on adults’ exposure to ACEs are either unavailable or incomplete for many U.S. states.
Methods Current estimates of the proportion of U.S. adults with past ACEs exposures were obtained by analysing individual-level data from 2019 to 2020 Behavioural Risk Factor Surveillance System―annual nationally representative survey of noninstitutionalized adults aged 18+years. Standardised questions measuring ACEs exposures (presence of household member with mental illness, substance abuse, or incarceration; parental separation; witnessing intimate partner violence; experiencing physical, emotional, or sexual abuse during childhood) were categorised into 0, 1, 2–3, or 4+ACEs and reported by sociodemographic group in each state. Missing ACEs responses (state did not offer ACEs questions or offered to only some respondents; respondent skipped questions) were modelled through multilevel mixed-effects logistic (MMEL) and jackknifed MMEL regressions.
Results In 2019–2020, an estimated 62.8% of U.S. adults had past exposure to 1+ACEs (range: 54.9% in Connecticut; 72.5% in Maine), including 22.4% of adults who were exposed to 4+ACEs (range: 11.9% in Connecticut; 32.8% in Nevada). At the national and state levels, exposure to 4+ACEs was highest among adults aged 18–34 years, those who did not graduate from high school, or adults who did not have a healthcare provider. Racial/ethnic distribution of adults exposed to 4+ACEs varied by age and state.
Conclusions ACEs are common but not equally distributed. ACEs exposures estimated by state and sociodemographic group can help decisionmakers focus public health interventions on populations disproportionately impacted in their area.
- Child abuse
- Statistical Issues
- Child
- Exposure
Statistics from Altmetric.com
WHAT IS ALREADY KNOWN ON THIS TOPIC
Although preventable, adverse childhood experiences (ACEs) are associated with lifelong negative health outcomes.
Current surveillance data on adults’ exposure to ACEs are unavailable for many states in the United States.
WHAT THIS STUDY ADDS
Estimates from a nationally representative survey for 2019–2020 demonstrated 22% of adults in the United States had past exposure to 4+ACEs (range: 12% in Connecticut; 33% in Nevada).
At national and state levels, exposure to 4+ACEs was highest among adults who did not graduate from high school, had no healthcare provider, or were aged 18–34 years. Racial/ethnic distribution of adults who were exposed to 4+ACEs varied considerably by age and state.
HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY
Public health and medical practitioners could optimise the targeting of interventions to prevent adverse childhood experiences by focusing on sociodemographic groups at higher risk in their state.
Introduction
Adverse childhood experiences (ACEs)―preventable, potentially traumatic childhood events―can result in lifelong negative health and socioeconomic effects, including increased risk of substance misuse, violence, sexually transmitted infections, maternal and child health problems, or limited access to life opportunities (eg, education or stable employment).1–5 Current surveillance data on adults’ exposure to ACEs is unavailable for many U.S. states. By 2020, all states included ACEs questions in at least one annual Behavioural Risk Factor Surveillance System (BRFSS) survey.6 However, some states last offered ACEs questions in 2011, altered questions’ language, or queried only a fraction of respondents,6–8 while in other states, up to 33% of BRFSS respondents skipped ACEs questions.9 Limitations of BRFSS data could have impacted interpretation of previously reported ACEs estimates.6 9 10 With some states last offering ACEs questions in 2011, differences in ACEs estimates across states may either reflect the actual differences in ACEs burden or be an artefact of delayed reporting. Altered language of ACEs questions might have affected respondents’ comprehension, complicating the comparison of ACEs estimates across states. Offering ACEs questions to a fraction of respondents in some states could have resulted in a small sample size, potentially limiting ACEs analyses by sociodemographic group in those states. High non-response rates for ACEs questions may trigger concerns about non-random responses.
In this study, current estimates of adults’ past exposure to ACEs―comparable across states and sociodemographic groups― were estimated using self-reported data from 2019 to 2020 BRFSS surveys, with missing ACEs responses (state did not offer ACEs questions in 2019–2020 or offered to only some respondents; respondents skipped questions) modelled through small area estimation (SAE) technique.11–14 ACEs estimates―stratified by sociodemographic group in each U.S. state―can help decisionmakers focus social, educational, and public health interventions on populations disproportionately impacted in their area.
Methods
Current by-state estimates of the proportion of U.S. adults exposed to 0, 1, 2–3, or 4+ACEs (ACEs score of 0, 1, 2–3, or 4+)5 6 9 were obtained by analysing individual-level ACEs data on adults aged 18+years from 2019 to 2020 BRFSS surveys.7 8 BRFSS is an annual, random-digit–dialled telephone survey conducted by all 50 states to collect self-reported information from U.S. adults aged 18+years who live in private residences or college housing. BRFSS is the largest telephone-based (landline and cellular telephone) survey of health behaviours and factors in the world, with 418 268 interviews completed in 2019 and 401 958 interviews completed in 2020 (median survey response rates of 49.4%/47.9% in 2019/2020, respectively). Because 2019–2020 BRFSS is a publicly available database that eliminates all patient identifiers, this study did not require institutional review board approval.
In 2019–2020 BRFSS, 37 U.S. states included standardised ACEs questions15 (presence of household member with mental illness, substance abuse, or incarceration; parental separation; witnessing intimate partner violence; experiencing physical, emotional, or sexual abuse during childhood; online supplemental etable 1). However, 8 out of 37 states offered ACEs questions to a random sample of 17–34% of survey respondents (online supplemental etable 2). Among those who received questions, ≤33% of respondents skipped at least one ACEs question and ≤28% skipped all questions (online supplemental etable 2). All missing ACEs responses (state did not offer ACEs questions or offered to only some respondents; respondent skipped questions) were modelled through SAE.11–14 Predictive SAE models―logistic regressions (LR) and multilevel mixed-effects LR (MMEL) performed on each ACEs score (Stata v17.0)―controlled for health/socioeconomic factors associated with ACEs,1 including individual-level factors from BRFSS (respondent’s sociodemographic characteristics, access to care, health outcomes associated with ACEs; online supplemental etable 3) and state-level factors from five additional sources16–20 (online supplemental etable 3). Models with best predictive performance were selected by comparing the non-missing ACEs scores directly estimated from BRFSS to modelled ACEs scores by using standard statistics (sensitivity/specificity, positive/negative predicted values, percent modelled to observed answers, and Pearson correlation coefficient). Survey-weighted estimates and 95% confidence intervals (CIs) by ACEs score were obtained from a combination of direct estimates (if reported in the survey) and modelled SAE estimates (if direct estimates were missing). For states that included ACEs questions in both 2019–2020 we combined both years,7 8 since data quality was comparable across years (comparable survey response rates7 8; stable direct ACEs estimates (online supplemental etable 4)). LR/MMEL examined associations between the survey-weighted individual-level ACEs proportions and respondents’ sociodemographic characteristics. Resampling methods―jackknifed MMEL/LR that leave out one state at a time―were used as sensitivity analyses, since they reduce possible state-specific non-response bias by resampling models with different ACEs non-response patterns.21 22
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Results
SAE models demonstrated high predictive performance,11 14 with modelled ACEs scores closely fitting directly estimated ACEs scores at the national and state levels for those survey respondents who answered ACEs questions (online supplemental etables 5–7). Sensitivity analysis underscored stability of model estimates, with the baseline MMEL/LR estimates plotted against the jackknifed MMEL/LR estimates tightly clustering around a 45 degree line (online supplemental efigure 1).
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Nationwide, an estimated 62.8% (95% CI=62.6% to 63.0%) of adults had past exposure to 1+ACE during childhood (range: 54.9% in Connecticut; 72.5% in Main), including 22.4% adults who were exposed to 4+ACEs (figure 1, table 1, online supplemental etable 6). Exposure to 4+ACEs was higher among females (26.6%; table 1) than males (17.9%), adults aged 18–34 years (30.9%) than 55+years (12.9%), adults who did not graduate from high school (29.6%) than adults who attended or graduated from college (20.3%), or adults who did not have a personal healthcare provider (27.9%) than adults who did (20.7%). Exposure to 4+ACEs varied substantially by race/ethnicity. Overall, exposure to 4+ACEs was higher among non-Hispanic American Indian or Alaskan Native adults (26.6%; table 1), Hispanic adults (24.8%), and non-Hispanic African Americans adults (24.0%) and lower among non-Hispanic White adults (21.8%), and non-Hispanic Asian adults (12.5%). However, when stratified by age to account for systematic age differences between non-Hispanic White respondents and other races/ethnicity categories (online supplemental etable 8), lower exposure to 4+ACEs among non-Hispanic White adults persisted chiefly for ages 55+years (figure 2). By contrast, for ages 18–34 years, non-Hispanic White adults had the highest exposure to 4+ACEs as compared with other races/ethnicities. At the state level, exposure to 4+ACEs ranged from 32.8% (figure 1, online supplemental etable 9) in Nevada to 11.9% in Connecticut. Exposure to 4+ACEs remained consistently higher among adults aged 18–34 years, those who did not graduate from high school, or adults who did not have a personal healthcare provider (online supplemental etable 9). When adjusted for age and sex, exposure to 4+ACEs among White non-Hispanic adults was higher or comparable to other races/ethnicities in 23 U.S. states (online supplemental etable 9).
Supplemental material
Supplemental material
Discussion
Exposure to ACEs is common among U.S. adults and varies substantially by state and sociodemographics. An estimated 62.8% of U.S. adults had past exposure to 1+ACEs, including 22.4% adults who were exposed to 4+ACEs. Past exposure to 4+ACEs at the national and state levels was highest among adults who did not graduate from high school or had no personal healthcare provider, supporting previous findings that exposure to multiple ACEs in childhood may limit opportunities later in life.9 High exposure to 4+ACEs among adults aged 18–34 years underscores the importance of preventative measures among children and adolescents. Overall, our findings highlight missed opportunities to lessen ACEs harms among adults who do not have access to medical care and underscore the necessity of evidence-based strategies to prevent ACEs, such as policies that ensure strong start for children (eg, early childhood home visitation programmes, high-quality childcare), policies that establish positive networks for adolescents (eg, connecting youth to caring teachers, coaches, or community volunteers), or policies that strengthen household financial security (eg, tax credits, childcare subsidies, livable wages),1 with state-specific interventions geared towards sociodemographic groups at higher risk for ACEs in each location.
By using SAE and standardised ACEs questions, this report filled in significant surveillance gaps by presenting current comparable ACEs estimates nationally and across all individual U.S. states (including states that skipped ACEs questions in their 2019–2020 BRFSS surveys). Additionally, this report estimated ACEs exposure for all survey respondents (including those who did not receive or skipped ACEs questions), thereby mitigating survey non-response bias and ensuring sufficient sample size to conduct analyses by sociodemographic group in each U.S. state.
The key results from this study are consistent with ACEs estimates from Swedo et al 6 for those states that recently included ACEs questions in their BRFSS surveys. For overlapping years, the difference between percentage of adults with past exposure to 4+ACEs from this study and from Swedo et al was greatest for Nevada (10.7 percentage points), of which 2.2 percentage points were attributable to model assumptions (online supplemental etable 10). The remaining 8.5 percentage point difference demonstrated that 33.1% of BRFSS respondents in Nevada who skipped ACEs questions in 2020 (respondents omitted in Swedo et al) were more likely to be exposed to 4+ACEs than respondents who answered the questions. For states that last included ACEs questions in 2011–2014, our estimates based on 2019–2020 data exceeded Swedo et al estimates based on 2011–2014 data, highlighting the need for a thorough analysis to explain 2011–2020 ACEs trends.
Supplemental material
Limitations
This study has several limitations. First, BRFSS relies on self-reported data that may be subject to recall bias.6 Second, BRFSS data are collected for private residences and exclude populations who might be particularly vulnerable to multiple ACEs exposures (eg, those incarcerated or homeless). Third, considering the complex nature of ACEs,1 predictive SAE model may not capture the impact of all factors associated with the outcome. Fourth, SAE could not address the survey non-participation bias, since BRFSS did not include the individual-level ACEs predictors for those eligible BRFSS respondents who were never available for an interview.7
Conclusions
These findings highlight opportunities for medical and public health practitioners to prevent ACEs or lessen harm among affected persons by focusing interventions on sociodemographic groups at higher risk in their state. A CDC-developed resource1 outlines activities with greatest potential for impact.
Ethics statements
Patient consent for publication
Ethics approval
Not applicable.
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Footnotes
Contributors All authors have participated sufficiently in the work to take public responsibility for its entire content. All authors participated in designing the study concept, analyzing and interpreting the data, drafting and critically revising the manuscript. Statistical analysis was conducted and verified by Aslam, Swedo, and Florence.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not–for–profit sectors.
Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.